Inactive Instrument

Advanced Biomedical Technologies, Inc. Stock Other OTC

Equities

ABMT

US00752M1018

Advanced Medical Equipment & Technology

Sales 2019 0.01 Sales 2020 0.12 Capitalization 10.71M
Net income 2019 - Net income 2020 - EV / Sales 2019 856,383,804 x
Net Debt 2019 5.74M Net Debt 2020 5.42M EV / Sales 2020 130,476,223 x
P/E ratio 2019
-4.48 x
P/E ratio 2020
-15.3 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 96.69%
More Fundamentals * Assessed data
Dynamic Chart
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2021 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Full Year Ended October 31, 2020 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2020 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2020 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2020 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Full Year Ended October 31, 2019 CI
Advanced Biomedical Technologies, Inc. Appoints Puyi Sheng as Chief Medical Officer CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2019 CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2019 CI
Advanced Biomedical Technologies Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws CI
Advanced Biomedical Technologies, Inc. Announces Chinese CFDA Approval of Polymer Fixation Screws CI
Advanced BioMedical Technologies, Inc. Auditor Raises 'Going Concern' Doubt CI
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013 CI
Advanced BioMedical Technologies, Inc. Auditor Raises 'Going Concern' Doubt CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 -
Director of Finance/CFO 54 -
Chairman 50 -
Members of the board TitleAgeSince
Chairman 50 -
Chief Executive Officer 54 -
Director of Finance/CFO 54 -
More insiders
Advanced Biomedical Technologies, Inc. is engaged in the business of designing, developing, manufacturing, and marketing of biomaterial internal fixation devices. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.
More about the company